News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide L.A. McKeown March 19, 2026
News Conference News CRT 2026 PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years L.A. McKeown March 17, 2026
News Conference News CRT 2026 CARPOOL Radial Access as Good as Femoral in PAD Procedures L.A. McKeown March 16, 2026
News Conference News CRT 2026 SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type L.A. McKeown March 16, 2026
News Conference News CRT 2026 AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis L.A. McKeown March 11, 2026
News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss L.A. McKeown November 07, 2025
News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Conference News EuroPCR 2025 Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS L.A. McKeown May 30, 2025
News Conference News SCAI 2025 Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers L.A. McKeown May 07, 2025
News Conference News SCAI 2025 BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients L.A. McKeown May 07, 2025
News Conference News SCAI 2025 Pain in the Neck? Operators Seek Solutions to Lead’s Weighty Toll L.A. McKeown May 05, 2025
News Conference News SCAI 2025 Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR L.A. McKeown May 02, 2025
News Conference News SCAI 2025 More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected L.A. McKeown May 02, 2025
News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs L.A. McKeown April 25, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025